Advisory Services Network’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $796K | Sell |
1,342
-662
| -33% | -$330K | 0.01% | 1041 |
|
|
2025
Q4 | $976K | Buy |
2,004
+5
| +0.3% | +$2.33K | 0.01% | 893 |
|
|
2025
Q3 | $838K | Sell |
1,999
-450
| -18% | -$151K | 0.01% | 957 |
|
|
2025
Q2 | $673K | Sell |
2,449
-1,047
| -30% | -$313K | 0.01% | 1028 |
|
|
2025
Q1 | $1.08M | Buy |
3,496
+661
| +23% | +$227K | 0.02% | 733 |
|
|
2024
Q4 | $1M | Buy |
2,835
+1,794
| +172% | +$659K | 0.02% | 743 |
|
|
2024
Q3 | $332K | Hold |
1,041
| – | – | 0.01% | 1166 |
|
|
2024
Q2 | $332K | Buy |
+1,041
| New | +$276K | 0.01% | 1166 |
|
|
2024
Q1 | – | Sell |
-210
| Closed | -$46.2K | – | 3562 |
|
|
2023
Q4 | $46.2K | Buy |
+210
| New | +$48.4K | ﹤0.01% | 2060 |
|
|
2023
Q2 | – | Sell |
-157
| Closed | -$35.2K | – | 3560 |
|
|
2023
Q1 | $35.2K | Sell |
157
-9
| -5% | -$2.22K | ﹤0.01% | 2214 |
|
|
2022
Q4 | $46.2K | Buy |
+166
| New | +$41.9K | ﹤0.01% | 2010 |
|
|
2021
Q3 | – | Sell |
-500
| Closed | -$90K | – | 3140 |
|
|
2021
Q2 | $90K | Buy |
+500
| New | +$95.2K | ﹤0.01% | 1671 |
|
|
2021
Q1 | – | Sell |
-533
| Closed | -$81K | – | 2867 |
|
|
2020
Q4 | $81K | Sell |
533
-11
| -2% | -$1.44K | ﹤0.01% | 1432 |
|
|
2020
Q3 | $55K | Buy |
+544
| New | +$59.7K | ﹤0.01% | 1544 |
|
|
2020
Q2 | – | Sell |
-437
| Closed | -$41K | – | 2657 |
|
|
2020
Q1 | $41K | Sell |
437
-206
| -32% | -$19.6K | ﹤0.01% | 1484 |
|
|
2019
Q4 | $57K | Sell |
643
-1,196
| -65% | -$105K | ﹤0.01% | 1432 |
|
|
2019
Q3 | $144K | Hold |
1,839
| – | – | 0.01% | 929 |
|
|
2019
Q2 | $144K | Buy |
+1,839
| New | +$172K | 0.01% | 927 |
|
|
2018
Q2 | – | Sell |
-100
| Closed | -$11K | – | 2702 |
|
|
2018
Q1 | $11K | Sell |
100
-850
| -89% | -$108K | ﹤0.01% | 1843 |
|
|
2017
Q4 | $141K | Sell |
950
-135
| -12% | -$17.2K | 0.01% | 880 |
|
|
2017
Q3 | $127K | Hold |
1,085
| – | – | 0.01% | 786 |
|
|
2017
Q2 | $141K | Hold |
1,085
| – | – | 0.02% | 722 |
|
|
2017
Q1 | $147K | Buy |
+1,085
| New | +$164K | 0.02% | 693 |
|
|
2016
Q3 | $140K | Sell |
1,185
-135
| -10% | -$16.2K | 0.03% | 604 |
|
|
2016
Q2 | $140K | Sell |
1,320
-44
| -3% | -$4.91K | 0.03% | 531 |
|
|
2016
Q1 | $152K | Buy |
1,364
+679
| +99% | +$85.9K | 0.04% | 433 |
|
|
2015
Q4 | $107K | Sell |
685
-365
| -35% | -$53.1K | 0.03% | 427 |
|
|
2015
Q3 | $138K | Sell |
1,050
-1,084
| -51% | -$174K | 0.04% | 345 |
|
|
2015
Q2 | $370K | Buy |
2,134
+2,025
| +1,858% | +$364K | 0.11% | 210 |
|
|
2015
Q1 | $19K | Hold |
109
| – | – | 0.01% | 707 |
|
|
2014
Q4 | $16K | Buy |
+109
| New | +$14K | 0.01% | 648 |
|
|
2014
Q1 | – | Sell |
-59
| Closed | -$7K | – | 771 |
|
|
2013
Q4 | $7K | Buy |
+59
| New | +$5.32K | ﹤0.01% | 700 |
|
Other funds holding UTHR
ACA
VPM
VCM
Advisory Services Network's UTHR Position: Q1 2026 in Review
Advisory Services Network reduced its United Therapeutics (UTHR) stake by 33% in Q1 2026, selling an estimated $330K and leaving 1,342 shares worth $796K. The position accounts for 0.01% of the portfolio, ranked #1041.
Advisory Services Network first reported a position in UTHR in Q4 2013 and has held it in 32 quarters since. The position peaked at $1.08M in Q1 2025. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.
- Advisory Services Network held 1,342 shares of United Therapeutics worth $796K as of Q1 2026.
- Advisory Services Network sold 662 United Therapeutics shares in Q1 2026, an estimated $330K.
- United Therapeutics made up 0.01% of Advisory Services Network's portfolio in Q1 2026, its #1041 holding.
- Advisory Services Network first reported a position in United Therapeutics in Q4 2013 and has held it in 32 quarters since.
- Advisory Services Network's United Therapeutics position peaked at $1.08M in Q1 2025.
- 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.
Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.